Following an application from Martek Biosciences Corporation submitted pursuant to Article 14(1)(b) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of docosahexaenoic acid (DHA) and arachidonic acid (ARA) on neural development of the brain and eyes (Question No EFSA-Q-2008-120) [11].
Pärast seda, kui Martek Biosciences Corporation oli esitanud määruse (EÜ) nr 1924/2006 artikli 14 lõike 1 punkti b kohase taotluse, pidi toiduohutusamet esitama arvamuse tervisealase väite kohta seoses dokosaheksaeenhappe (DHA) ja arahhidoonhappe (ARA) mõjuga aju ja silmade neuraalsele arengule (küsimus nr EFSA-Q-2008-120) [11].